Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
FENIX OUTDOOR INTERNATIONAL AGDelårsrapport2026-01-01 – 2026-03-31 Första kvartalet 2026-01-01 – 2026-03-31 Koncernens rörelseintäkter uppgick till TEUR 168 465 (TEUR 160 082), en ökning med...
-
FENIX OUTDOOR INTERNATIONAL AGInterim condensed consolidated financial statements for the period ended 31 March 2026 First quarter 2026-01-01 – 2026-03-31 The total income of the Group was TEUR...
-
Solna 2026-04-27 Fenix Outdoor International AG, a global leader in the development and sale of premium apparel and equipment for outdoor life has today signed a term sheet with the ambition to...
-
Solna 2026-04-27 Fenix Outdoor International AG, a global leader in the development and sale of premium apparel and equipment for outdoor life has today signed a term sheet with the ambition to...
-
We announce that the Management Board convenes the annual general meeting of the shareholders of AS Pro Kapital Grupp (registration code 10278802, hereinafter the Company), which shall take place on...
-
AS Pro Kapital Grupp (registrikood 10278802, edaspidi Ühing) juhatus kutsub kokku aktsionäride korralise üldkoosoleku, mis toimub teisipäeval, 26. mail, 2026.a. algusega kell 12.15 (09.15 UTC),...
-
We announce that the Management Board convenes the annual general meeting of the shareholders of AS Pro Kapital Grupp (registration code 10278802, hereinafter the Company), which shall take place on...
-
REYKJAVIK, Iceland, April 24, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar...
-
REYKJAVÍK (24. apríl 2026) – Alvotech (NASDAQ: ALVO) mun birta uppgjör fyrsta ársfjórðungs 2026 þann 6. maí nk., eftir lokun markaða í Bandaríkjunum. Fundur til kynningar á uppgjörinu verður sendur út...
-
REYKJAVIK, ICELAND (April 24, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...